Best Software Tools for Time-to-Event Analyses in Clinical Trials

Time-to-event (TTE) analysis—commonly used to evaluate survival, disease progression, or treatment failure—is a cornerstone of clinical trials, especially in oncology and chronic disease studies. Robust software tools are essential for implementing survival analysis techniques like Kaplan-Meier estimation, log-rank tests, and Cox proportional hazards models. This guide highlights the most widely used and validated software solutions for survival analysis in pharmaceutical settings.

Whether you are part of a biostatistics team, clinical data group, or regulatory submission unit, choosing the right tool is critical to accuracy, compliance, and effective communication. This tutorial provides a comparative overview of the top platforms, their strengths, and recommended use cases in alignment with CDSCO and USFDA expectations.

Key Requirements for Survival Analysis Software

• Validated and audit-ready per 21 CFR Part 11
• Ability to handle censored data
• Built-in functions for Kaplan-Meier, log-rank, and Cox regression
• Support for graphical outputs (survival curves, forest plots)
• Reproducible code or audit trail
• Integration with CDISC standards and submission formats

All tools should support compliant workflows and standardized reporting, aligning with Pharma SOP documentation for statistical processes.

1. R and the ‘survival’ Package

Overview: R is an open-source statistical programming language widely used for clinical trial analysis. The survival package is its cornerstone for TTE analysis.

Key Functions:

• survfit(): Kaplan-Meier estimation
• coxph(): Cox proportional hazards modeling
• survdiff(): Log-rank test
• ggsurvplot(): Enhanced visualization using ‘survminer’

R allows complete control over data and graphical output, making it ideal for publications, regulatory appendices, and internal reports. However, validation and version control are required for compliant use in GxP environments.

2. SAS (Statistical Analysis System)

Overview: SAS is a gold-standard commercial tool in the pharmaceutical industry, offering strong validation, audit trails, and regulatory acceptance.

Key Procedures:

• PROC LIFETEST: Kaplan-Meier and log-rank test
• PROC PHREG: Cox regression
• ODS Graphics: Automated KM curve generation

SAS is especially preferred for its integration with CDISC/ADaM datasets and seamless export to submission formats. It supports stability study tracking through macro-driven automation.

3. STATA

Overview: STATA offers a GUI-based and command-line interface with powerful survival analysis capabilities, commonly used in academic and international trials.

Key Functions:

• sts graph: Kaplan-Meier plots
• stcox: Cox regression
• stcurve: Custom survival curve generation
• Supports time-varying covariates and stratified models

STATA is ideal for exploratory work and mixed-model survival analysis. Its graphical outputs are high quality and journal-ready.

4. SPSS (Statistical Package for the Social Sciences)

Overview: While less common in regulatory trials, SPSS remains a user-friendly option for early-phase or academic research in survival analysis.

Key Features:

• KM survival curves with click-based customization
• Cox regression via GUI or syntax
• Good for training and teaching environments

SPSS is best suited for smaller trials or institutions that need quick exploratory insights without the complexity of full coding.

5. Python and the ‘lifelines’ Package

Overview: Python is gaining traction in clinical research. The lifelines package enables full survival modeling with elegant syntax and rich visualization.

Highlights:

• KaplanMeierFitter(): KM estimation
• CoxPHFitter(): Proportional hazards model
• Integrated plotting via Matplotlib
• Great for automation and reproducibility in modern workflows

Python is useful for algorithm-driven studies and automation, especially when paired with pharma validation tools for script certification.

Comparison Table

Best Practices When Using Survival Tools

1. Pre-define survival endpoints and censoring rules in SAP
2. Use validated software per regulatory requirements
3. Maintain audit trails and version control for scripts
4. Annotate Kaplan-Meier curves with number-at-risk and medians
5. Use appropriate tools for Cox assumption testing
6. Embed outputs into CSR and GMP documentation

Regulatory Submission Considerations

When using any of these tools for clinical trial data analysis:

• Ensure output files are traceable and reproducible
• Provide scripts or macros in submission datasets (per ICH E3 and E9)
• Align outputs with ADaM data structures for survival (e.g., ADSL and ADTTE)
• Document software versions and libraries used

Conclusion: Choose the Right Tool for the Right Analysis

Time-to-event analyses demand precision, transparency, and regulatory readiness. From the flexibility of R and Python to the robustness of SAS and STATA, selecting the right survival analysis software is a strategic decision. Each platform brings unique benefits, and your choice should reflect the trial phase, submission needs, and internal validation capacity. By aligning tools with SOPs, statistical plans, and regulatory frameworks, pharma professionals can ensure survival analysis supports both scientific insight and approval success.